Xeljanz (Tofacitinib)
Xeljanz (tofacitinib) is an oral treatment originally developed at the National Institutes of Health through collaboration with Pfizer. The U.S. Food and Drug Administration approved Xeljanz as a treatment for rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It has also been used…